Review Article on Analytical and Characterization Techniques in High Throughput Crystallization

Authors

  • Kaushal Kumar  Department of Pharmacy, M.J.P. Rohilkhand University, Bareilly, Uttar Pradesh, India

Keywords:

HT Crystallization Plates, Crystallization Process, Polymorphs, Pseudopolymorphs, Cocrystals, Salts, Amorphous

Abstract

In High Throughput crystallization process, when crystallization has occurred, the HT crystallization plates are passed for the analysis for identification of the produced solid forms under each set of test conditions. Multiple approaches for physical form discovery must be used so as to maximize the number of forms encountered during the search. Once all solid-state forms produced in the screen are identified, each form is fully characterized through determination of crystal structure and establishing thermodynamic relationships between forms and relative thermodynamic stabilities.

References

  1. Byrn, S. et al. “Pharmaceutical solids: a strategic approach to regulatory considerations”. Pharm. Res.  1995; 12: 945–954.
  2. Ann newman. “Specialized Solid Form Screening Techniques”. Org. Process Res. Dev. 2013, 17, 3, 457–471.
  3. Guillory, J. K. In Polymorphism in Pharmaceutical Solids; Marcel Dekker: New York, 1999; Chapter 5, p 183.
  4. Hilfiker, R. In Polymorphism in the Pharmaceutical Industry; Wiley-VCH: Weinheim, Ger., 2006; Chapter 11, p 287.
  5. Maiwald, M. Am. Pharm. Rev. 2006, 9, 95
  6. O’Neill, M. Pharm. Technol. 2003, 44
  7. Aaltonen, J; Alleso, M; Mirza, S; Koradia, V; Gordon, K. C.; Rantanen, J. Eur. J. Pharm. Biopharm. 2009, 71, 23
  8. Chawla, G.; Banga, S.; Bansal, A. V. Bus. Briefing: Future Drug Discovery 2004, March) 66
  9. C. Challener. “Polymorph screening for identification of relevant crystalline forms”, Pharmaceutical Technology 40 (3) 2016: 32-35.
  10. Alastair J Florence. “Polymorph screening in pharmaceutical development”. European Pharmaceutical review. 2010; (4).
  11. Kumar L, Amin A, Bansal AK. “An Overview of automated systems relevant in pharmaceuticalsalt screening”. Drug Discovery Today.2007; 12 (23/24): 1046-1053.
  12. Stephens G A. “Applications of X-ray powder diffraction in the pharmaceutical industry”. Rigaku J.2005; 22: 2-15.
  13. Remenar J F et al. “Salt selection and simultaneous polymorphism assessment via high-throughput crystallization: the case of sertraline”. Org. Process Res. Dev.2003; 7:990-996.
  14. Carlson E D et al. “Polymorph characterization”. Symyx Technologies. EP 1467205A 1.
  15. Alastair J Florence. “Polymorph screening in pharmaceutical development”. European Pharmaceutical review. 2010; (4).
  16. https://kiko-tech.co.jp/wp2019/wp-content/uploads/2017/03/Application-Note-High-throughput-polymorph-screening-of-API.pdf
  17. Edwin Lewis. “High Throughput DSC for drug screening”. SBIR STTR America Seed Fund.  2005. Solicitation number: PHS2005-2.
  18. Offerdahl T J. “Solid-State Nuclear Magnetic Resonance Spectroscopy for Analyzing Polymorphic Drug Forms and Formulations”. Pharmaceutical Technology.2006; (1).
  19. Vogt F G et al., "Determination of Molecular Geometry in Solid-State NMR: Rotational-Echo Double Resonance of Three Spin Systems," J. Phys. Chem. 2003; B 107 (5): 1272–1283.
  20. Tishmack P A, Bugay D E, Byrn S R. "Solid-State Nuclear Magnetic Resonance Spectroscopy—Pharmaceutical Applications," J. Pharm. Sci. 2003; 92 (3): 441– 474.

International Journal of Scientific Research in Science and Technology

Downloads

Published

2019-01-20

Issue

Volume 6, Issue 1, January-February-2019

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Kaushal Kumar, " Review Article on Analytical and Characterization Techniques in High Throughput Crystallization, International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 6, Issue 1, pp.702-707, January-February-2019.